ALG-006162

N/A

Report date: 2025/03/19 16:06:40
NME

Base Information

Drug NameALG-006162
Drug Alias NameALG-006162
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg inhibitorsHepatitis B virus capsid protein modulators
TargetsHepatitis B Surface AntigensHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAligos Belgium BV
China Registration ClassN/A

Develop Information

Active CompaniesAligos Belgium BV
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A